ELElyda Golçalves De Lima

Elyda Golçalves De Lima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elyda Golçalves De Lima has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evolução da inteligência artificial como uma ferramenta para administração

    by Hugo Félix, Jadson Freire da Silva, Elyda Gonçalves de Lima, Ryân da Silva Rocha, Nathália Costa Carvalho

    Objetivo: O presente estudo foi desenvolvido de modo a analisar as maneiras que a inteligência artificial (IA) vem sendo utilizada como ferramenta para otimizar processos administrativos. Para tanto, debruça-se sobre as produções acadêmicas de administração e áreas correlatas sobre o tema. Método/abordagem: Uma revisão bibliográfica qualitativa foi adotada, baseada em artigos científicos disponíveis na plataforma SPELL, com seleção e análise de 22 estudos publicados entre 2020 e 2024, utilizando a palavra-chave "Inteligência Artificial" Contribuições teóricas/práticas/sociais: Ao sistematizar as discussões acadêmicas sobre IA na administração, o estudo identificou duas principais perspectivas: seu uso em instituições públicas e em diversos setores da Administração. Logo, o estudo aponta o crescimento da popularidade de softwares em técnicas administrativas que já foram ponderadas por pesquisadores desta área de estudos. Além disso, indica o crescente alerta sobre implicações éticas e limitações das IA. Originalidade/relevância: O estudo contribui ao mapear tendências recentes e ao consolidar o papel da IA como ferramenta estratégica para a tomada de decisões em um ambiente organizacional dinâmico e complexo.


  • Open Access

    Detection of Human Papillomavirus DNA in Paired Peripheral Blood and Cervix Samples in Patients with Cervical Lesions and Healthy Individuals

    by Kamylla Conceição Gomes Nascimento, Élyda Gonçalves Lima, Zhilbelly Mota Nunes, Marconi Rêgo Barros Júnior, Marcus Vinícius de Aragão Batista, Antonio Roberto Lucena Araujo, Jacinto da Costa Silva Neto, Bárbara Simas Chagas, Ana Pavla Almeida Diniz Gurgel, Antonio Carlos de Freitas

    This study evaluated the presence of Human Papillomavirus (HPV) DNA in the cervix and peripheral blood of women with cervical intraepithelial neoplasia (CIN I, II, and III) and healthy individuals. Overall, 139 paired peripheral blood and cervix samples of healthy women and women with CIN I, II, and III (n = 68) were tested for HPV DNA by using standard procedures. Polymerase chain reaction (PCR) sequencing determined HPV types. Quantification of HPV16 E6 and E2 genes was performed to determine viral load and physical state. HPV DNA was detected in the cervix (21.1% in healthy individuals; 48.8–55.5% in CIN patients), blood (46.4% in healthy individuals; 44.1–77.7% in CIN patients) and paired peripheral blood and cervix samples (24% in healthy individuals; 32.5–44.4% in CIN patients). The most frequent types found in the cervix were HPV16, 18, 31, 33, 58, and 70, while HPV16, 18, 33, 58, and 66 were the most frequent types found in the blood. HPV DNA in the cervix was associated with previous sexually transmitted infections (STIs) (p = 0.023; OR: 2.978; CI:1.34–7.821), HPV DNA in the blood (p = 0.000; OR: 8.283; CI:3.700–18.540), and cervical lesions (CIN I/II or III) (p = 0.007). Binomial logistic regression showed that HPV DNA in the blood (p = 0.000; OR: 9.324; CI:3.612–24.072) and cervical lesions (p = 0.011; OR: 3.622; CI:1.338–9.806) were associated with HPV DNA in the cervix. However, we did not find an association between HPV DNA in the blood and cervical lesions (p = 0.385). Our results showed that only HPV DNA found in the cervix was associated with cervical lesions.


  • Human papillomavirus and lung cancinogenesis: an overview

    by Antonio Carlos De Freitas, Ana Pavla Gurgel, Elyda Golçalves De Lima, Bianca De França São Marcos, Carolina Maria Medeiros Do Amaral

    Lung cancer is the most common cause of cancer deaths worldwide. Although tobacco smoking is considered to be the main risk factor and the most well-established risk factor for lung cancer, a number of patients who do not smoke have developed this disease. This number varies between 15 % to over one-half of lung cancer cases, and the deaths from lung cancer in non-smokers are increasing every year. There are many other agents that are thought to be etiological, including diesel exhaust exposure, metals, radiation, radon, hormonal factors, cooking oil, air pollution and infectious diseases, such as human papillomavirus (HPV). Studies in various parts of the world have detected HPV DNA at different rates in lung tumors. However, the role of HPV in lung cancer is still unclear. Thus, in this review, we investigated some molecular mechanisms of HPV protein activity in host cells, the entry of HPV into lung tissue and the possible route used by the virus to reach the lung cells.